Which neurotransmitter is primarily responsible for parasympathetic effects on heart rate?
The PR interval in ECG denotes?
PR interval in ECG shows?
Cardiac event at the end of isometric relaxation phase:
All are true about S1 except:
A hormone involved in regulation of blood pressure is:
As a general rule, arteries carry :
Which of the following uses cGMP as a second messenger?
The non-invasive method to measure the blood flow is:
Atrial natriuretic peptide causes:
Explanation: ***Acetylcholine*** - **Acetylcholine** is the primary neurotransmitter released by postganglionic parasympathetic neurons. - It acts on **muscarinic receptors** (M2 receptors) in the heart to decrease heart rate. *Norepinephrine* - **Norepinephrine** is primarily associated with the **sympathetic nervous system**, increasing heart rate and contractility. - It acts on **beta-1 adrenergic receptors** in the heart. *Dopamine* - **Dopamine** is a precursor to norepinephrine and epinephrine, and primarily functions as a neurotransmitter in the **central nervous system** and in regulating renal blood flow. - While it can have cardiac effects, it is not the primary neurotransmitter for parasympathetic actions on heart rate. *Epinephrine* - **Epinephrine** (adrenaline) is a hormone released by the adrenal medulla and a neurotransmitter in the sympathetic nervous system, causing an **increase in heart rate** and contractility. - It works through **beta-1 adrenergic receptors**, antagonistic to parasympathetic effects.
Explanation: ***Atrial depolarization with A - V conduction*** * The **PR interval** reflects the time from the beginning of **atrial depolarization** (P wave) to the beginning of **ventricular depolarization** (QRS complex). * It represents the time taken for the electrical impulse to travel through the **atria** and the **AV node** to the ventricles. *Ventricular depolarization and ventricular repolarization* * **Ventricular depolarization** is represented by the **QRS complex**, and **ventricular repolarization** is represented by the **T wave**. * The PR interval occurs before the QRS complex, not during ventricular depolarization or repolarization. *Atrial depolarization with atrial repolarization* * **Atrial depolarization** is represented by the **P wave**. * **Atrial repolarization** typically occurs simultaneously with **ventricular depolarization** (QRS complex) and is often obscured by it. The PR interval includes the P wave but extends beyond it. *Atrial depolarization only* * **Atrial depolarization** is solely represented by the **P wave**. * The PR interval is a longer duration that includes the P wave and the subsequent delay in the **AV node**.
Explanation: ***Atrial depolarization and conduction delay*** - The **PR interval** is measured from the **beginning of the P wave** to the **beginning of the QRS complex**. - It represents the **complete time** for the electrical impulse to travel from the SA node through the atria, the AV node, the Bundle of His, and bundle branches until ventricular depolarization begins. - This includes two major components: 1. **Atrial depolarization** (represented by the P wave) 2. **Conduction delay** through the AV node and His-Purkinje system (the isoelectric segment after the P wave) - **Normal PR interval**: 0.12-0.20 seconds (120-200 ms) - The **AV nodal delay** is the longest component, allowing atrial contraction to complete before ventricular contraction begins. *Conduction through AV node* - While **AV nodal conduction** is an important component of the PR interval, this option is **incomplete**. - The PR interval begins with the **P wave** (atrial depolarization), which occurs before the impulse reaches the AV node. - Stating only "conduction through AV node" ignores the atrial depolarization component that is also part of the PR interval. *Delay in ventricular depolarization* - **Ventricular depolarization** is represented by the **QRS complex**, not the PR interval. - The PR interval *ends* when ventricular depolarization begins (start of QRS). *Delay in ventricular repolarization* - **Ventricular repolarization** is represented by the **T wave** on an ECG. - This occurs much later in the cardiac cycle and is not related to the PR interval.
Explanation: ***Atrioventricular valves open*** - This event marks the end of isometric relaxation, where ventricular pressure has dropped below atrial pressure, allowing the **mitral and tricuspid valves** to open and ventricular filling to begin. - During **isometric relaxation**, the ventricles relax without changing volume, causing a rapid drop in intraventricular pressure until it is overcome by atrial pressure. *Corresponds to T wave in ECG* - The **T wave** on an ECG represents **ventricular repolarization**, which occurs during the early part of ventricular diastole, *before* the end of isometric relaxation when the AV valves open. - The opening of AV valves occurs a bit later, as ventricular filling phase commences. *Atrioventricular valves close* - The closing of the **atrioventricular valves** (mitral and tricuspid) occurs at the beginning of **isovolumetric contraction (systole)**, not at the end of isometric relaxation (diastole). - This event marks the start of ventricular systole and is associated with the **first heart sound (S1)**. *Corresponds to peak of C wave in JVP* - The **C wave** in the jugular venous pressure (JVP) tracing corresponds to the bulging of the **tricuspid valve** into the right atrium during early ventricular systole, immediately after the AV valves close. - This event is distinct from the end of isometric relaxation, which occurs later in diastole, *before* atrial filling.
Explanation: ***heard at the end of ventricular systole*** - The **S1 sound** marks the **beginning of ventricular systole**, not the end. - It occurs immediately after the atria have emptied their blood into the ventricles and before the ventricles begin to pump blood out. *better heard with diaphragm of stethoscope* - **S1** is a **high-pitched sound** produced by the closing of the **mitral and tricuspid valves**. - High-pitched sounds are best auscultated with the **diaphragm** of the stethoscope. *caused by closure of mitral valve* - **S1** is primarily caused by the simultaneous closure of the **mitral and tricuspid valves**. - The **mitral valve closure** contributes the most to the intensity and timing of S1, as it handles higher pressures. *lower frequency than s2* - **S1** has a **lower frequency** and longer duration compared to **S2**. - This is because the closure of the **AV valves** (mitral and tricuspid) produces lower-pitched sounds than the closure of the semilunar valves.
Explanation: ***Angiotensin- II*** - **Angiotensin II** is a potent **vasoconstrictor** that directly increases **blood pressure** by narrowing blood vessels. - It also stimulates **aldosterone** release, leading to **sodium and water retention**, further contributing to increased blood volume and blood pressure. *Serotonin* - **Serotonin** (5-hydroxytryptamine or **5-HT**) plays a role in mood, sleep, and appetite, but its direct role in systemic **blood pressure regulation** is less prominent than **Angiotensin II**. - While it can affect vascular tone locally, it is not considered a primary hormonal regulator of overall systemic BP. *Dopamine* - **Dopamine** is a neurotransmitter involved in motor control, reward, and motivation, and at low doses can cause **renal vasodilation**. - Its direct and sustained role in systemic **blood pressure regulation** is not as central as the **renin-angiotensin-aldosterone system**. *Prostaglandin* - **Prostaglandins** are lipid compounds that act as local hormones, with some (**PGE2**, **PGI2**) causing **vasodilation** and others (**PGF2α**) causing **vasoconstriction**. - They are more involved in localized inflammatory responses, blood flow to specific organs (e.g., kidneys), and pain, rather than serving as a primary systemic regulator of ongoing **blood pressure**.
Explanation: ***Oxygenated blood*** - Arteries are generally responsible for carrying **oxygenated blood** away from the heart to the rest of the body's tissues and organs. - The only exception is the **pulmonary artery**, which carries deoxygenated blood from the heart to the lungs. *Urine* - Urine is transported by the **ureters** from the kidneys to the bladder, and then by the urethra out of the body. - This is part of the **urinary system**, separate from the circulatory system. *Deoxygenated blood* - While veins primarily carry **deoxygenated blood** back to the heart, arteries generally carry oxygenated blood. - The exception is the **pulmonary artery**, which carries deoxygenated blood to the lungs for oxygenation. *Lymph fluid* - **Lymph fluid** is carried by the lymphatic system, a network of vessels and nodes that is part of the immune system. - The lymphatic system helps maintain fluid balance and fights infection, distinct from the circulatory function of arteries.
Explanation: ***Atrial natriuretic peptide*** - **Atrial natriuretic peptide (ANP)** primarily uses **cGMP** as its second messenger to exert its effects on the cardiovascular system and kidneys. - ANP binds to its receptor, activating **guanylate cyclase**, which then converts **GTP to cGMP**, leading to vasodilation and natriuresis. *Cortisone* - **Cortisone** is a **glucocorticoid** that primarily functions by binding to intracellular **steroid hormone receptors**, which then translocate to the nucleus to regulate gene expression. - It does not utilize cGMP as a second messenger; its signaling pathway involves direct gene transcription modulation. *GH* - **Growth hormone (GH)** typically signals through the **JAK/STAT pathway** upon binding to its receptor, leading to the phosphorylation of STAT proteins and subsequent gene transcription. - GH primarily stimulates cell growth and metabolism through tyrosine kinase-associated receptors, not via cGMP. *Thyroxine* - **Thyroxine (T4)** and its active form **triiodothyronine (T3)** are **thyroid hormones** that bind to nuclear receptors, influencing gene expression directly. - Their mechanism of action involves altering protein synthesis, and they do not use cGMP as a second messenger.
Explanation: ***Laser Doppler flowmetry*** - This method uses **laser light** to measure blood flow in the microvasculature by detecting the **Doppler shift** caused by moving red blood cells. - It is a **non-invasive**, real-time technique used to assess blood perfusion in tissues, particularly useful for microvascular flow assessment. - Commonly applied in research and clinical settings to evaluate **skin perfusion**, **peripheral circulation**, and **microvascular function**. *Doppler ultrasound* - While **Doppler ultrasound** is also non-invasive and measures blood flow velocity using the Doppler principle, it is typically used for **larger vessels** rather than microcirculation. - It provides information about **blood flow velocity** and direction in arteries and veins, not the detailed microvascular perfusion that Laser Doppler provides. *Plethysmography* - **Plethysmography** measures volume changes in an organ or limb, which can reflect blood flow indirectly. - It is non-invasive but provides information about **total blood volume changes** rather than direct, real-time microvascular blood flow measurement. - Types include venous occlusion plethysmography and impedance plethysmography. *Fick's principle* - **Fick's principle** is used to measure cardiac output by calculating the difference in oxygen content between arterial and venous blood. - While valuable for measuring overall blood flow (cardiac output), it requires **blood sampling** or breath analysis, making it less directly non-invasive compared to Laser Doppler flowmetry for microvascular assessment.
Explanation: ***All of the options*** - **Atrial natriuretic peptide (ANP)** has multiple integrated effects on the cardiovascular and renal systems, making all the listed options correct. **Vasodilation** - ANP causes **vasodilation** of both afferent and efferent renal arterioles (with greater effect on afferent), as well as systemic blood vessels - This vasodilation directly reduces systemic vascular resistance and blood pressure - Mediated through cGMP-dependent mechanisms **Promotes natriuresis by inhibiting sodium reabsorption** - ANP directly **inhibits sodium reabsorption** in the collecting duct by: - Antagonizing aldosterone effects - Inhibiting epithelial sodium channels (ENaC) - Reducing sodium transport in the distal nephron - This promotes natriuresis (sodium excretion) and diuresis (water excretion) **Increases glomerular filtration rate by acting via mesangial cells** - ANP increases **GFR** through multiple mechanisms: - Causes **relaxation of mesangial cells**, which increases glomerular capillary surface area available for filtration - Dilates afferent arteriole more than efferent, increasing glomerular capillary hydrostatic pressure - These combined effects significantly enhance glomerular filtration *Vasodilation alone* - While vasodilation is one important effect of ANP, it is not the only mechanism by which ANP regulates blood volume and pressure *Promotes natriuresis by inhibiting sodium reabsorption alone* - While natriuresis through sodium reabsorption inhibition is a key mechanism, ANP has additional important effects *Increases GFR by acting via mesangial cells alone* - While the mesangial cell relaxation and GFR increase are correct, ANP's actions are more comprehensive
Cardiac Electrophysiology
Practice Questions
Cardiac Cycle
Practice Questions
Cardiac Output and Its Regulation
Practice Questions
Hemodynamics and Blood Flow
Practice Questions
Arterial System Physiology
Practice Questions
Microcirculation and Lymphatics
Practice Questions
Venous Return and Central Venous Pressure
Practice Questions
Cardiovascular Reflexes
Practice Questions
Regional Circulations
Practice Questions
Cardiovascular Responses to Exercise and Stress
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free